Announcement on behalf of APBio’s resolution to lift non-competition restrictions for directors at 2022 extraordinary Shareholders' Meeting

Announcement on behalf of AP Biosciences. regarding its by-election of director and supervisor at 2022 first extraordinary General Shareholders' Meeting

Announcement on behalf of AP Biosciences’ important resolutions of 2022 first extraordinary General Shareholders' Meeting

Announcement of the Consolidated Financial Statements for the third quarter of 2022 were approved by the Board of Directors

The Chairman decided the record date of 2022 first issuance of RSU according to the resolution Of BOD

Announcement on behalf of AP Biosciences that the BOD resolved to convene 2022 first extraordinary General Shareholders' Meeting

OBI-822 “Cancer Immunotherapy by Immune Activation or Immune Modulation via Globo Series Antigens“ was granted by USPTO

Announcement on behalf of AP Biosciences of the resignation of its institutional director

OBI PHARMA INC. to attend investor conference hosted by MASTERLINK SECURITIES

Announcement of AP Biosciences’ full receipt of cash capital increase in 2022 and the reference date of capital increase